Free Trial

Shield Therapeutics (STX) Competitors

Shield Therapeutics logo
GBX 3 0.00 (0.00%)
As of 03/28/2025 12:16 PM Eastern

STX vs. ELX, APC, STK, DGI, IDEA, VLG, DNL, EAH, PXS, and CHLL

Should you be buying Shield Therapeutics stock or one of its competitors? The main competitors of Shield Therapeutics include El Oro (ELX), Apc Technology Group (APC), StreaksAI (STK), DG Innovate (DGI), Ideagen (IDEA), Venture Life Group (VLG), Diurnal Group (DNL), ECO Animal Health Group (EAH), Provexis (PXS), and Chill Brands Group (CHLL).

Shield Therapeutics vs.

Shield Therapeutics (LON:STX) and El Oro (LON:ELX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk.

El Oro has lower revenue, but higher earnings than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than El Oro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shield Therapeutics£20.92M1.42-£36.28M-£3.88-0.77
El Oro-£7.25M0.00N/A-£2.50N/A

Shield Therapeutics received 162 more outperform votes than El Oro when rated by MarketBeat users. Likewise, 75.17% of users gave Shield Therapeutics an outperform vote while only 59.55% of users gave El Oro an outperform vote.

CompanyUnderperformOutperform
Shield TherapeuticsOutperform Votes
215
75.17%
Underperform Votes
71
24.83%
El OroOutperform Votes
53
59.55%
Underperform Votes
36
40.45%

El Oro has a net margin of 0.00% compared to Shield Therapeutics' net margin of -173.43%. El Oro's return on equity of 0.00% beat Shield Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Shield Therapeutics-173.43% -470.50% -47.85%
El Oro N/A N/A N/A

11.9% of Shield Therapeutics shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Shield Therapeutics' average media sentiment score of 0.00 equaled El Oro'saverage media sentiment score.

Company Overall Sentiment
Shield Therapeutics Neutral
El Oro Neutral

Summary

Shield Therapeutics beats El Oro on 6 of the 10 factors compared between the two stocks.

Remove Ads
Get Shield Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STX vs. The Competition

MetricShield TherapeuticsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£29.61M£2.27B£5.63B£2.60B
Dividend YieldN/A2.92%4.57%4.82%
P/E Ratio-0.774.2123.33141.06
Price / Sales1.42575.41388.34281,678.23
Price / Cash6.3610.2538.1627.98
Price / Book54.826.556.894.61
Net Income-£36.28M£20.70B£3.20B£5.78B
7 Day Performance-4.06%-2.69%-2.98%1.37%
1 Month Performance-9.91%-2.92%1.63%7.24%
1 Year Performance48.15%92.67%9.44%111.87%

Shield Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STX
Shield Therapeutics
N/AGBX 3
flat
N/A+48.1%£29.61M£20.92M-0.7740,000Gap Down
ELX
El Oro
N/AN/AN/AN/A£41.06M£-7,248,605.00-26.001,122
APC
Apc Technology Group
N/AN/AN/AN/A£18.03M£19.20M19.75164,000
STK
StreaksAI
N/AGBX 0.67
-0.7%
N/A+18.2%£2.52MN/A-32.503
DGI
DG Innovate
N/AN/AN/AN/A£1.90M£24,500.00-1.25790Gap Down
IDEA
Ideagen
N/AN/AN/AN/A£1.03B£75.28M17,450.009News Coverage
VLG
Venture Life Group
N/AGBX 41.20
+0.5%
N/A+11.0%£52.50M£51.77M69.92165
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
EAH
ECO Animal Health Group
N/AGBX 58.36
-0.2%
N/A-34.5%£39.55M£89.44M37.73234
PXS
Provexis
N/AGBX 0.50
+4.8%
N/A-18.5%£11.69M£846,984.38-18.884Gap Up
High Trading Volume
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007
Remove Ads

Related Companies and Tools


This page (LON:STX) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners